Page last updated: 2024-08-22

clodronic acid and Hyperparathyroidism, Primary

clodronic acid has been researched along with Hyperparathyroidism, Primary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Accadia, M; Capozza, M; Chinellato, I; Di Lorgi, N; Di Mauro, A; Guarnieri, V; Laforgia, N; Mattioli, G; Traggiai, C1
Kuo, SW; Lee, IT; Pei, D; Sheu, WH; Tu, ST1

Other Studies

2 other study(ies) available for clodronic acid and Hyperparathyroidism, Primary

ArticleYear
Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation.
    BMC pediatrics, 2018, 10-30, Volume: 18, Issue:1

    Topics: Bone Density Conservation Agents; Calcimimetic Agents; Cinacalcet; Clodronic Acid; Diphosphonates; Female; Fluid Therapy; Furosemide; Genes, Recessive; Homozygote; Humans; Hyperparathyroidism, Primary; Infant, Newborn; Infant, Newborn, Diseases; Mutation; Parathyroidectomy; Receptors, Calcium-Sensing

2018
Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism.
    Journal of bone and mineral metabolism, 2006, Volume: 24, Issue:3

    Topics: Adult; Aged; Calcium; Clodronic Acid; Diphosphonates; Female; Humans; Hyperparathyroidism, Primary; Hypocalcemia; Male; Middle Aged; Pamidronate; Parathyroidectomy; Preoperative Care; Retrospective Studies; Syndrome

2006